Qingfang Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qingfang Xu has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Wei Lai
Department of Dermatology and Venereology, the Third Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510630, P.R. China
6 shared publications Mengting Ouyang
Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
4 shared publications- Yue Zheng
Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China
4 shared publications Hongpeng Li
Department of Dermato-Venereology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, P. R. China
3 shared publications- Jiaqi Fang
Department of Dermato-Venereology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, P. R. China
3 shared publications Jingjing Lan
Department of Dermato-Venereology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, P. R. China
3 shared publications
Latest Publications
- Open Access
- 6 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 6044
Estrogen Promotes Melanogenesis Through Facilitating M2 Macrophage Skewing in Melasma
Although estrogen has been identified to play crucial roles in the development of melasma, the exact mechanism of estrogen’s effect on pigmentation is incompletely elucidated. Recent studies have highlighted the pivotal role of immune cells in melasma. Interestingly, infiltrated macrophages are significantly enhanced in melasma lesions. Estrogen could facilitate M2 polarization. However, whether estrogen could stimulate melanogenesis via skewing M2 phenotype remains unknown. This study attempted to determine the significance and molecular mechanism of estrogen-induced M2 phenotype in melasma. We found that M2 infiltration was significantly increased in melasma lesions compared with perilesional skin. Arginase 1 was identified as the hub gene, and its expression was positively correlated with that of microphthalmia-associated transcription factor and tyrosinase-related protein 1 in melasma through transcriptome analysis. Moreover, β-estradiol (E2) was confirmed to promote M2 skewing while inhibiting M1 polarization via activating STAT6 signaling. Importantly, E2-induced M2 polarization robustly increased melanogenesis by increasing tyrosinase activity and expression of microphthalmia-associated transcription factor and tyrosinase in melanocytes, which were profoundly inhibited by VEGF knockdown or antagonism both in vitro and in ex vivo skin. Furthermore, VEGF was revealed to enhance melanogenesis through activating p38 MAPK and ERK1/2 signaling pathways in melanocytes. Additionally, dermal VEGF was significantly increased, and most of it colocalized with M2 macrophages in melasma lesions. Crucially, E2 administration potently reversed ovariectomy-decreased M2 skewing and subsequently promoted dermal VEGF expression and epidermal melanogenesis in the mouse tail skin, which were significantly suppressed by macrophage depletion. These findings suggest that estrogen may stimulate melanogenesis in melasma through increasing M2 skewing and VEGF expression and secretion in macrophages.
- 6 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (13) , 6044
Open AccessEstrogen Promotes Melanogenesis Through Facilitating M2 Macrophage Skewing in Melasma
Although estrogen has been identified to play crucial roles in the development of melasma, the exact mechanism of estrogen’s effect on pigmentation is incompletely elucidated. Recent studies have highlighted the pivotal role of immune cells in melasma. Interestingly, infiltrated macrophages are significantly enhanced in melasma lesions. Estrogen could facilitate M2 polarization. However, whether estrogen could stimulate melanogenesis via skewing M2 phenotype remains unknown. This study attempted to determine the significance and molecular mechanism of estrogen-induced M2 phenotype in melasma. We found that M2 infiltration was significantly increased in melasma lesions compared with perilesional skin. Arginase 1 was identified as the hub gene, and its expression was positively correlated with that of microphthalmia-associated transcription factor and tyrosinase-related protein 1 in melasma through transcriptome analysis. Moreover, β-estradiol (E2) was confirmed to promote M2 skewing while inhibiting M1 polarization via activating STAT6 signaling. Importantly, E2-induced M2 polarization robustly increased melanogenesis by increasing tyrosinase activity and expression of microphthalmia-associated transcription factor and tyrosinase in melanocytes, which were profoundly inhibited by VEGF knockdown or antagonism both in vitro and in ex vivo skin. Furthermore, VEGF was revealed to enhance melanogenesis through activating p38 MAPK and ERK1/2 signaling pathways in melanocytes. Additionally, dermal VEGF was significantly increased, and most of it colocalized with M2 macrophages in melasma lesions. Crucially, E2 administration potently reversed ovariectomy-decreased M2 skewing and subsequently promoted dermal VEGF expression and epidermal melanogenesis in the mouse tail skin, which were significantly suppressed by macrophage depletion. These findings suggest that estrogen may stimulate melanogenesis in melasma through increasing M2 skewing and VEGF expression and secretion in macrophages.
- 10 March 2026
- Published by Elsevier in Journal of Dermatological Science
- Vol. 122 (2) , 55-65
A novel ZIC1–BMP4 axis identified in photoaged dermal fibroblasts regulates melanogenesis
- 10 March 2026
- Published by Elsevier in Journal of Dermatological Science
- Vol. 122 (2) , 55-65
A novel ZIC1–BMP4 axis identified in photoaged dermal fibroblasts regulates melanogenesis
- 16 July 2024
- Published by Springer Nature in Inflammation
- Vol. 48 (2) , 919-934
YTHDF2 Regulates Advanced Glycation End Products-Induced Melanogenesis through Inhibiting A20 Expression in Human Dermal Fibroblasts
Fibroblast A20 suppresses advanced glycation end products (AGEs)-induced melanogenesis by inhibiting NLRP3 inflammasome activation. AGEs repress A20 expression and significantly m6A-methylate A20 mRNA in fibroblasts. YTHDF2 is the most studied m6A reader protein and can accelerate degradation of m6A-modified mRNA. Whether YTHDF2 regulates AGEs-induced A20 expression and pigmentation is unknown. In this study, we confirmed that YTHDF2 inversely regulated AGEs-BSA-inhibited A20 expression but facilitated AGEs-BSA-activated NF-κB signaling and NLRP3 inflammasome in fibroblasts via YTHDF2 knockdown and overexpression experiments. Mechanistically, YTHDF2 bound to m6A-modified A20 mRNA induced by AGEs-BSA and increased its degradation. Moreover, fibroblast YTHDF2 robustly promoted AGEs-BSA-induced IL-18 level in coculture supernatants and melanin content, tyrosinase activity, and expression of microphthalmia-associated transcription factor and tyrosinase in melanocytes, which were significantly blocked by IL-18 binding protein. Further, fibroblast YTHDF2 markedly increased AGEs-BSA-induced epidermal melanin level in cocultured ex vivo skin and MAPKs activation in melanocytes. Importantly, upregulated dermal YTHDF2 expression was negatively correlated with dermal A20 level and positively associated with both epidermal melanin and dermal AGEs content in sun-exposed skin and lesions of melasma and solar lentigo. These findings suggest that fibroblast YTHDF2 positively regulates AGEs-induced melanogenesis mainly via A20/ NF-κB /NLRP3 inflammasome/ IL-18 /MAPKs axis in an m6A-dependent manner and functions in photoaging-induced hyperpigmentation skin disorders.
- 16 July 2024
- Published by Springer Nature in Inflammation
- Vol. 48 (2) , 919-934
YTHDF2 Regulates Advanced Glycation End Products-Induced Melanogenesis through Inhibiting A20 Expression in Human Dermal Fibroblasts
Fibroblast A20 suppresses advanced glycation end products (AGEs)-induced melanogenesis by inhibiting NLRP3 inflammasome activation. AGEs repress A20 expression and significantly m6A-methylate A20 mRNA in fibroblasts. YTHDF2 is the most studied m6A reader protein and can accelerate degradation of m6A-modified mRNA. Whether YTHDF2 regulates AGEs-induced A20 expression and pigmentation is unknown. In this study, we confirmed that YTHDF2 inversely regulated AGEs-BSA-inhibited A20 expression but facilitated AGEs-BSA-activated NF-κB signaling and NLRP3 inflammasome in fibroblasts via YTHDF2 knockdown and overexpression experiments. Mechanistically, YTHDF2 bound to m6A-modified A20 mRNA induced by AGEs-BSA and increased its degradation. Moreover, fibroblast YTHDF2 robustly promoted AGEs-BSA-induced IL-18 level in coculture supernatants and melanin content, tyrosinase activity, and expression of microphthalmia-associated transcription factor and tyrosinase in melanocytes, which were significantly blocked by IL-18 binding protein. Further, fibroblast YTHDF2 markedly increased AGEs-BSA-induced epidermal melanin level in cocultured ex vivo skin and MAPKs activation in melanocytes. Importantly, upregulated dermal YTHDF2 expression was negatively correlated with dermal A20 level and positively associated with both epidermal melanin and dermal AGEs content in sun-exposed skin and lesions of melasma and solar lentigo. These findings suggest that fibroblast YTHDF2 positively regulates AGEs-induced melanogenesis mainly via A20/ NF-κB /NLRP3 inflammasome/ IL-18 /MAPKs axis in an m6A-dependent manner and functions in photoaging-induced hyperpigmentation skin disorders.
- 9 January 2024
- Published by Elsevier in Journal of Dermatological Science
- Vol. 114 (3) , 124-132
FTO-mediated regulation of m6A methylation is closely related to apoptosis induced by repeated UV irradiation
- 9 January 2024
- Published by Elsevier in Journal of Dermatological Science
- Vol. 114 (3) , 124-132
FTO-mediated regulation of m6A methylation is closely related to apoptosis induced by repeated UV irradiation
- 28 September 2023
- Published by Springer Nature in Genes & Genomics
- Vol. 45 (12) , 1549-1562
Identification of genomic-wide genetic links between cutaneous melanoma and obesity-related physical traits via cFDR
Background Both epidemiological and clinical studies have suggested the comorbidity between cutaneous melanoma (CM) and obesity-related physical traits. However, it remains unclear about their shared genetic architecture. Objective To determine the shared genetic architecture between CM and obesity-related physical traits through conditional false discovery rate (cFDR) analysis. Method Quantile–quantile plots were firstly built to assess the pleiotropic enrichment of shared single nucleotide polymorphisms between CM and each trait. Then, cFDR and conjunctional cFDR (ccFDR) were used to identify the shared risk loci between CM and each trait. Moreover, the functional evaluation of shared risk genes was carried out through analyses of expression quantitative trait loci (eQTL), Kyoto Encyclopedia of Genes and Genomes and gene ontology, respectively. Finally, single-cell sequence analysis was performed to locate the expression of eQTL-mapped genes in tissues. Results Successive pleiotropic enrichment was found between CM and 5 obesity-related traits or height. 24 shared risk loci were identified between CM and 13 traits except appendicular lean mass using ccFDR analysis, with 17 novel and 4 validated loci. The functions of ccFDR-identified and eQTL-mapped genes were revealed to be mainly involved in cellular senescence, proliferation, meiotic nuclear division, cell cycle, and the metabolism of lipid, cholesterol and glucose. Single-cell sequence analysis showed that keratinocytes contribute to the occurrence and aggressiveness of CM through secreting paracrine cytokines. Conclusion Our findings demonstrate the significant genetic correlation between CM and obesity-related physical traits, which may provide a novel genetical basis for the pathogenesis and treatment of CM.
- 28 September 2023
- Published by Springer Nature in Genes & Genomics
- Vol. 45 (12) , 1549-1562
Identification of genomic-wide genetic links between cutaneous melanoma and obesity-related physical traits via cFDR
Background Both epidemiological and clinical studies have suggested the comorbidity between cutaneous melanoma (CM) and obesity-related physical traits. However, it remains unclear about their shared genetic architecture. Objective To determine the shared genetic architecture between CM and obesity-related physical traits through conditional false discovery rate (cFDR) analysis. Method Quantile–quantile plots were firstly built to assess the pleiotropic enrichment of shared single nucleotide polymorphisms between CM and each trait. Then, cFDR and conjunctional cFDR (ccFDR) were used to identify the shared risk loci between CM and each trait. Moreover, the functional evaluation of shared risk genes was carried out through analyses of expression quantitative trait loci (eQTL), Kyoto Encyclopedia of Genes and Genomes and gene ontology, respectively. Finally, single-cell sequence analysis was performed to locate the expression of eQTL-mapped genes in tissues. Results Successive pleiotropic enrichment was found between CM and 5 obesity-related traits or height. 24 shared risk loci were identified between CM and 13 traits except appendicular lean mass using ccFDR analysis, with 17 novel and 4 validated loci. The functions of ccFDR-identified and eQTL-mapped genes were revealed to be mainly involved in cellular senescence, proliferation, meiotic nuclear division, cell cycle, and the metabolism of lipid, cholesterol and glucose. Single-cell sequence analysis showed that keratinocytes contribute to the occurrence and aggressiveness of CM through secreting paracrine cytokines. Conclusion Our findings demonstrate the significant genetic correlation between CM and obesity-related physical traits, which may provide a novel genetical basis for the pathogenesis and treatment of CM.
- 7 September 2023
- Published by Elsevier in Journal of Dermatological Science
- Vol. 112 (2) , 71-82
A20 ameliorates advanced glycation end products-induced melanogenesis by inhibiting NLRP3 inflammasome activation in human dermal fibroblasts
- 7 September 2023
- Published by Elsevier in Journal of Dermatological Science
- Vol. 112 (2) , 71-82
A20 ameliorates advanced glycation end products-induced melanogenesis by inhibiting NLRP3 inflammasome activation in human dermal fibroblasts
- 11 April 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (10) , 2591-2602.e8
Advanced Glycation End Products Promote Melanogenesis by Activating NLRP3 Inflammasome in Human Dermal Fibroblasts
- 11 April 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (10) , 2591-2602.e8
Advanced Glycation End Products Promote Melanogenesis by Activating NLRP3 Inflammasome in Human Dermal Fibroblasts
- 14 March 2022
- Published by Taylor & Francis in Epigenomics
- Vol. 14 (8) , 431-449
Advanced Glycation End Products Alter the M 6 A-Modified RNA Profiles in Human Dermal Fibroblasts
Background: To explore advanced glycation end products (AGEs)-induced m6A modification in fibroblasts and its potential role in photoaging. Methods: We studied m6A modification in AGEs-bovine serum...
- 14 March 2022
- Published by Taylor & Francis in Epigenomics
- Vol. 14 (8) , 431-449
Advanced Glycation End Products Alter the M 6 A-Modified RNA Profiles in Human Dermal Fibroblasts
Background: To explore advanced glycation end products (AGEs)-induced m6A modification in fibroblasts and its potential role in photoaging. Methods: We studied m6A modification in AGEs-bovine serum...
- Open Access
- 1 January 2021
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 33 (5) , 463-466
Novel Point Mutation of EBSS Gene Coexisted with 1p36 Deletion
Zheng Y, et al. Ann Dermatol. 2021 Oct;33(5):463-466. https://doi.org/10.5021/ad.2021.33.5.463
- 1 January 2021
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 33 (5) , 463-466
Open AccessNovel Point Mutation of EBSS Gene Coexisted with 1p36 Deletion
Zheng Y, et al. Ann Dermatol. 2021 Oct;33(5):463-466. https://doi.org/10.5021/ad.2021.33.5.463
- 6 October 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (6) , 1875-1884
Predicting miRNA‐lncRNA‐mRNA network in ultraviolet A‐induced human skin photoaging
Background/Objective: Recent researches had reported that microRNAs (miRNAs) played a role in skin photoaging. Our previous study found that long noncoding RNA (lncRNA) expression was changed in the UVA‐irradiated skin fibroblasts, but the regulating network of noncoding RNA in UV‐induced skin changes has not been elucidated well. Here, we investigated the interactions of miRNA‐lncRNA‐mRNAs in skin photoaging mechanisms.Methods: Human dermal fibroblasts (HDFs) were irradiated with UVA at 10 J/cm2 once a day lasting for 14 days. miRNA expression profiles were detected by high‐throughput sequencing. miRNAs changed significantly were identified by qRT‐PCR. Functional annotation analysis and pathway enrichment were carried out using Gene Ontology and KEGG, and predicted miRNA‐lncRNA‐mRNA interactions were performed via bioinformatic analysis.Results: 34 differentially expressed miRNAs (>1.5‐fold changes, P < .05) after UVA irradiation were identified to interact with distinct lncRNAs. miRNA‐lncRNA‐mRNA network prediction and regulatory role analysis showed that the gene expression of cellular process, cell part, and binding was mainly coordinated in UVA‐irradiated fibroblasts. miRNA‐lncRNA‐mRNA‐signal transduction pathway analysis showed that TNF signaling pathway, thyroid hormone signaling pathway, and lysosome were mainly affected after UVA irradiation.Conclusion: miRNA‐lncRNA‐mRNA network played a critical part in skin photoaging. Our research provided novel insights into the repeated UVA‐induced skin damage in noncoding RNA regulatory field and might help to further understand the delicate interplay of gene regulation at the noncoding RNA level in photoaged skin and UV‐induced skin cancers in future researching and provide novel insights into the repeated UVA‐damaging pathology and potential targets for preventing human skin photoaging.
- 6 October 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (6) , 1875-1884
Predicting miRNA‐lncRNA‐mRNA network in ultraviolet A‐induced human skin photoaging
Background/Objective: Recent researches had reported that microRNAs (miRNAs) played a role in skin photoaging. Our previous study found that long noncoding RNA (lncRNA) expression was changed in the UVA‐irradiated skin fibroblasts, but the regulating network of noncoding RNA in UV‐induced skin changes has not been elucidated well. Here, we investigated the interactions of miRNA‐lncRNA‐mRNAs in skin photoaging mechanisms.Methods: Human dermal fibroblasts (HDFs) were irradiated with UVA at 10 J/cm2 once a day lasting for 14 days. miRNA expression profiles were detected by high‐throughput sequencing. miRNAs changed significantly were identified by qRT‐PCR. Functional annotation analysis and pathway enrichment were carried out using Gene Ontology and KEGG, and predicted miRNA‐lncRNA‐mRNA interactions were performed via bioinformatic analysis.Results: 34 differentially expressed miRNAs (>1.5‐fold changes, P < .05) after UVA irradiation were identified to interact with distinct lncRNAs. miRNA‐lncRNA‐mRNA network prediction and regulatory role analysis showed that the gene expression of cellular process, cell part, and binding was mainly coordinated in UVA‐irradiated fibroblasts. miRNA‐lncRNA‐mRNA‐signal transduction pathway analysis showed that TNF signaling pathway, thyroid hormone signaling pathway, and lysosome were mainly affected after UVA irradiation.Conclusion: miRNA‐lncRNA‐mRNA network played a critical part in skin photoaging. Our research provided novel insights into the repeated UVA‐induced skin damage in noncoding RNA regulatory field and might help to further understand the delicate interplay of gene regulation at the noncoding RNA level in photoaged skin and UV‐induced skin cancers in future researching and provide novel insights into the repeated UVA‐damaging pathology and potential targets for preventing human skin photoaging.